Samsung Biologics to kick off $1.5B+ plant construction in South Korea
The CDMO giant Samsung Biologics will be starting the construction of its manufacturing plant at the Songdo site in South Korea.
Samsung announced today that it will invest over $1.5 billion in the new facility. The CDMO plans to break ground on the plant sometime in the first half of 2023, with it fully operational by 2025.
The new plant, dubbed Plant 5, will also be the first piece to Samsung Biologic’s new Bio Campus, known as Bio Campus II. The facility will be 96,000 square meters or around 1,033,335 square feet and will be able to have a capacity of 180,000 liters of product. Once Plant 5 is complete, this will bring the CDMO’s manufacturing capacity to a total of 784,000 liters of product.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.